Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Rescuing and Repurposing Drugs: Challenges and Opportunities
Track : Track 17: Rare/Orphan Diseases
Program Code: 385
Date: Wednesday, June 26, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 205B
CHAIR :
 Cindy Luxhoj Hahn, (SCHSUP), President and CEO, Alagille Syndrome Alliance, United States
SPEAKER (S):
 Ciara Kennedy, PhD,MBA,MSc (SPKNON), Vice President, Operations, Lumena Pharmaceuticals, United States
 Larissa Lapteva, (SPKAGY), Medical Officer, Rare Diseases Program, Office of New Drugs, CDER, FDA, United States
 John C. McKew, PhD (SPKAGY), Acting Scientific Director, Division of Preclinical Innovation TRND, BrIDGs, National Center for Advancing Translational Sciences (NCATS), United States
Description
Drug rescue and repurposing presents an opportunity to spur the drug development process by building upon previous research and development efforts. However, this strategy also has challenges, particularly related to treatments for rare/orphan diseases.

Session Recording
(Code: 385)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 385)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Rescuing and Repurposing Drugs: Challenges and Opportunities